Cysteine rich protective antigen

Product list

The leading vaccine candidates for a P. falciparum blood-stage malaria vaccine are members of a heterotrimeric complex containing reticulocyte-binding protein homolog 5 (RH5), cysteinerich protective antigen (CyRPA), and RH5-interacting protein (RIPR), collectively called the "RCR complex"15. Each member of this complex is highly conserved, essential for erythrocyte invasion, and capable of inducing cross-strain neutralizing antibodies. The leading blood-stage malaria vaccine candidate, CyRPA, is essential for invasion of Plasmodium falciparum into human erythrocytes.

Show More Close

Inquiry

Anti-CyRPA Neutralizing Antibody (V3S-0522-YC945) (CAT#: V3S-0522-YC945)

Target: CyRPA

Host Species: Mouse

Target Species: Plasmodium falciparum,

Application: ELISA,WB,Inhib,